Cynata Files Application to Commence Phase 2 Clinical Trial in Critical Limb Ischaemia
MELBOURNE, Australia, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), announced today that it has filed a Clinical Trial Authorisation application with the UK Medicines and …